D.E. Shaw & Co’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-16,921
| Closed | -$79K | – | 2750 |
|
|
2017
Q4 | $79K | Sell |
16,921
-264,379
| -94% | -$1.23M | ﹤0.01% | 2462 |
|
|
2017
Q3 | $2M | Buy |
281,300
+111,721
| +66% | +$793K | ﹤0.01% | 1465 |
|
|
2017
Q2 | $1.23M | Buy |
169,579
+43,011
| +34% | +$311K | ﹤0.01% | 1645 |
|
|
2017
Q1 | $780K | Sell |
126,568
-53,703
| -30% | -$331K | ﹤0.01% | 1818 |
|
|
2016
Q4 | $1.06M | Buy |
180,271
+152,588
| +551% | +$894K | ﹤0.01% | 1728 |
|
|
2016
Q3 | $147K | Sell |
27,683
-1,569
| -5% | -$8.33K | ﹤0.01% | 2373 |
|
|
2016
Q2 | $194K | Sell |
29,252
-230,968
| -89% | -$1.53M | ﹤0.01% | 2391 |
|
|
2016
Q1 | $1.22M | Buy |
260,220
+102,995
| +66% | +$481K | ﹤0.01% | 1649 |
|
|
2015
Q4 | $794K | Buy |
157,225
+38,664
| +33% | +$195K | ﹤0.01% | 1876 |
|
|
2015
Q3 | $417K | Sell |
118,561
-67,159
| -36% | -$236K | ﹤0.01% | 2119 |
|
|
2015
Q2 | $1.85M | Buy |
185,720
+173,805
| +1,459% | +$1.73M | ﹤0.01% | 1520 |
|
|
2015
Q1 | $152K | Sell |
11,915
-76,664
| -87% | -$978K | ﹤0.01% | 2405 |
|
|
2014
Q4 | $1.25M | Buy |
88,579
+34,340
| +63% | +$486K | ﹤0.01% | 1590 |
|
|
2014
Q3 | $746K | Buy |
54,239
+20,651
| +61% | +$284K | ﹤0.01% | 1695 |
|
|
2014
Q2 | $517K | Sell |
33,588
-39,753
| -54% | -$612K | ﹤0.01% | 1876 |
|
|
2014
Q1 | $1.25M | Sell |
73,341
-641,932
| -90% | -$10.9M | ﹤0.01% | 1486 |
|
|
2013
Q4 | $9.26M | Buy |
715,273
+211,206
| +42% | +$2.73M | 0.01% | 644 |
|
|
2013
Q3 | $5.09M | Sell |
504,067
-187,557
| -27% | -$1.89M | 0.01% | 835 |
|
|
2013
Q2 | $5.17M | Buy |
+691,624
| New | +$5.17M | 0.01% | 788 |
|